ROME, Italy—Fatigue, a problem experienced frequently by patients with rheumatic diseases, is best thought of as a survival mechanism and as a single phenomenon, not a condition that comes in a variety of forms, an expert said in a session at EULAR 2015, the annual congress of the European League Against Rheumatism (EULAR). Gene Regulated…
A report from the Institute of Medicine that gives new diagnostic criteria for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and recommends a new name for the disorder received mixed reviews from rheumatologists and other physicians.1 “Diagnosing ME/CFS often is a challenge … the new diagnostic criteria will make it easier for clinicians to recognize and accurately…
Study suggests updating the ACR’s core set outcomes to gauge effect of fatigue on patients
Researchers find that genes, gender, and cognition all contribute to fatigue in rheumatoid arthritis (RA)
Researchers explore several factors in the health and well-being of patients with lupus
AIM modules provide a tool for physicians seeking a quality-improvement program and a way to meet new ACGME competencies or the American Board of Internal Medicine’s Maintenance of Certification Program requirements.
Experts share tips for building & managing a profitable rheumatology infusion practice, from staffing & billing to inventory & drug costs.
ACR Convergence 2025 speakers reviewed new fibromyalgia insights, from the first new drug approval since 2009 to nociplastic pain concepts & cognitive behavioral therapy.
Dr. David Pisetsky curated the research presented at ACR Convergence 2025 and answers the question “What new research on psoriatic arthritis has the potential to impact patient care or future research?”
Meet the 2025 ARP President’s & Merit Award recipients honored for their significant contributions to rheumatology research, education & patient care.